239 related articles for article (PubMed ID: 19219754)
21. PET/CT and radiotherapy in prostate cancer.
De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021
[TBL] [Abstract][Full Text] [Related]
22. Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors.
Lambrecht M; Haustermans K
Radiother Oncol; 2010 Sep; 96(3):339-46. PubMed ID: 20727606
[TBL] [Abstract][Full Text] [Related]
23. Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers.
Haie-Meder C; Mazeron R; Magné N
Radiother Oncol; 2010 Sep; 96(3):351-5. PubMed ID: 20709417
[TBL] [Abstract][Full Text] [Related]
24. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning.
Sattler B; Lee JA; Lonsdale M; Coche E
Radiother Oncol; 2010 Sep; 96(3):288-97. PubMed ID: 20709416
[TBL] [Abstract][Full Text] [Related]
25. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.
Hoshikawa H; Mitani T; Nishiyama Y; Yamamoto Y; Ohkawa M; Mori N
Auris Nasus Larynx; 2009 Apr; 36(2):192-8. PubMed ID: 18606510
[TBL] [Abstract][Full Text] [Related]
27. Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer.
Dandekar P; Partridge M; Kazi R; Nutting C; Harrington K; Newbold K
Indian J Cancer; 2010; 47(3):260-6. PubMed ID: 20587900
[TBL] [Abstract][Full Text] [Related]
28. Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.
Abramyuk A; Appold S; Zöphel K; Baumann M; Abolmaali N
Strahlenther Onkol; 2013 Mar; 189(3):197-201. PubMed ID: 23329277
[TBL] [Abstract][Full Text] [Related]
29. [Utility of PET-CT on radiotherapy planning of head and neck cancer. Our initial experience].
Bellón Guardia ME; Pérez Romasanta L; García Vicente AM; Talavera Rubio MP; Palomar Muñoz A; González García B; Poblete García VM; Soriano Castrejón A
Rev Esp Med Nucl; 2010; 29(4):157-64. PubMed ID: 20494489
[TBL] [Abstract][Full Text] [Related]
30. Head and neck malignancy: is PET/CT more accurate than PET or CT alone?
Branstetter BF; Blodgett TM; Zimmer LA; Snyderman CH; Johnson JT; Raman S; Meltzer CC
Radiology; 2005 May; 235(2):580-6. PubMed ID: 15858097
[TBL] [Abstract][Full Text] [Related]
31. [Current strategies in radiotherapy of head- and neck cancer].
Wenz F; Pütz M
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S144-50. PubMed ID: 22456915
[TBL] [Abstract][Full Text] [Related]
32. Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography.
Horiuchi C; Taguchi T; Yoshida T; Nishimura G; Kawakami M; Tanigaki Y; Matsuda H; Mikami Y; Oka T; Inoue T; Tsukuda M
Auris Nasus Larynx; 2008 Mar; 35(1):103-8. PubMed ID: 17825512
[TBL] [Abstract][Full Text] [Related]
33. Clinical use of PET-CT data for radiotherapy planning: what are we looking for?
Chiti A; Kirienko M; Grégoire V
Radiother Oncol; 2010 Sep; 96(3):277-9. PubMed ID: 20727607
[No Abstract] [Full Text] [Related]
34. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
Podoloff DA; Advani RH; Allred C; Benson AB; Brown E; Burstein HJ; Carlson RW; Coleman RE; Czuczman MS; Delbeke D; Edge SB; Ettinger DS; Grannis FW; Hillner BE; Hoffman JM; Kiel K; Komaki R; Larson SM; Mankoff DA; Rosenzweig KE; Skibber JM; Yahalom J; Yu JM; Zelenetz AD
J Natl Compr Canc Netw; 2007 May; 5 Suppl 1():S1-22; quiz S23-2. PubMed ID: 17509259
[TBL] [Abstract][Full Text] [Related]
35. Best practices: consensus on performing positron emission tomography-computed tomography for radiation therapy planning and for therapy response assessment.
Blodgett T
Semin Ultrasound CT MR; 2010 Dec; 31(6):506-15. PubMed ID: 21147378
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M
HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113
[TBL] [Abstract][Full Text] [Related]
37. ¹⁸F-FDG PET and PET/CT patient preparation: a review of the literature.
Surasi DS; Bhambhvani P; Baldwin JA; Almodovar SE; O'Malley JP
J Nucl Med Technol; 2014 Mar; 42(1):5-13. PubMed ID: 24503347
[TBL] [Abstract][Full Text] [Related]
38. PET/CT in head and neck oncology: State-of-the-art 2013.
Johnson JT; Branstetter BF
Laryngoscope; 2014 Apr; 124(4):913-5. PubMed ID: 24515562
[TBL] [Abstract][Full Text] [Related]
39. Role of positron emission tomography (PET) in head and neck cancer.
Duet M; Hugonnet F; Faraggi M
Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Mar; 127(1):40-5. PubMed ID: 20822756
[TBL] [Abstract][Full Text] [Related]
40. PET/CT of esophageal cancer: its role in clinical management.
Bruzzi JF; Munden RF; Truong MT; Marom EM; Sabloff BS; Gladish GW; Iyer RB; Pan TS; Macapinlac HA; Erasmus JJ
Radiographics; 2007; 27(6):1635-52. PubMed ID: 18025508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
